Pediatric anxiety is rapidly increasing, and in 2022, the US Preventive Services Task Force recommended universal anxiety screening using a validated tool for children 8-18 years.

Children and adolescents with neurodevelopmental and psychiatric comorbidities, particularly autism spectrum disorder and developmental delays (ASD/DD), present unique challenges in pediatric emergency department (PED) settings. Youths with ASD/DD are prone to sensory overload and frequently exhibit agitation and/or aggression, necessitating specialized interventions. However, PEDs lack standardized protocols for managing behavioral dysregulation in this vulnerable population, often relying on anecdotal treatment approaches that hinder the provision of safe, effective and individualized care.

In natural disasters, children encounter serious health problems.

The complexity of healthcare is dynamic and requires educators to evaluate how to prepare pediatric nurse practitioners (PNPs). The research team sought to evaluate procedures currently being performed by primary and acute care PNPs in clinical practice and determine how this aligns with the educational preparation recommended for certification.

Primary care physicians (PCPs) and nurse practitioners play a key role in guiding caregivers on early peanut protein (PP) introduction, yet many lack adequate knowledge.

Behavioral and mental health (BMH) issues are increasing in adolescents as shortages of primary care and BMH providers are also rising. The healthcare burden has fallen especially hard on primary care providers (PCPs), who are showing increasing signs of burnout and making plans to reduce their work hours or leave the profession altogether. These factors impede their ability to be the first line of defense in providing emotional support to children and families. Current solutions to BMH provider shortages include integrated models for primary and BMH health care and child psychiatric consultation services for PCPs. However, this does not diminish PCP perceptions that they are doing more screening and struggling to offer BMH support, all within shorter visit times. In this paper, we explore potential solutions to increasing time with patients and efficiency of primary care visits, and proposals to increase reimbursement for primary care providers.

This scoping review examines the application and evolution of the Social-Ecological Model for Adolescent and Young Adult Readiness for Transition (SMART). SMART provides a framework for assessing transition readiness across pediatric chronic conditions. Evaluating its research and clinical applications identifies insights and gaps across conditions and stakeholders.

Uncontrolled pediatric asthma leads to poorer outcomes; school-based telehealth (SBTH) is an opportunity to intervene.

Respiratory syncytial virus (RSV) is a common respiratory tract infection that causes bronchiolitis and pneumonia in infants and children. It is the leading cause of hospitalization of infants in the United States. Nirsevimab is a long-acting monoclonal antibody recommended for the prevention of severe disease in all infants under 8 months of age and certain high-risk toddlers. Recent data demonstrate a 90% protection against hospitalization from severe RSV disease for infants who received nirsevimab in their first RSV season. Providers should understand the mechanism of action, safety, efficacy, and prescribing recommendations for nirsevimab, especially when confronted with caregivers who are hesitant about medications and vaccines. Special circumstances may require nuanced prescribing of nirsevimab to safely provide optimal protection. In these circumstances, and during drug shortages, a lens of health equity should be used to protect the highest risk populations.

The present study investigated the relationship between screen use and social-emotional problems in preschoolers aged 46 to 72 months from migrant families.

Understanding caregiver willingness to participate in pediatric clinical research is needed. We examined caregiver perceptions of pediatric clinical research during COVID-19 and examined research attitudes and sociodemographic factors as predictors of willingness.

Screening for depression in caregivers of children with developmental disabilities is not routine, representing missed opportunities for support.

Suicidal ideation in the pediatric population has increased by 50% over the last decade. Suicide is the primary contributor to violent deaths and ranks as the second leading cause of mortality within the 10-24-year-old age group. The lethality of the methods selected notably elevates the likelihood of children and adolescents dying by suicide. Awareness of the commonly chosen means of suicide at each developmental stage and understanding their respective lethality are vital in developing prevention strategies. Lethal means safety counseling is a specific evidence-based suicide prevention strategy that pediatric providers can use during patient encounters to help mitigate the risk of self-inflicted injuries and suicide. Providers are well-positioned to integrate discussions of lethal means restriction with patients and their families into their protocols for suicide prevention, screening, and assessment. This article explores the data and practice evidence for lethal means restriction and counseling, focusing on clinical strategies and policy changes to reduce access to lethal means. Emphasis is given to how pediatric providers speak with parents about the importance of restricting access when developing a safety plan.

Transgender individuals may face familial and social hostility, leading to distress that significantly affects their well-being. This study aims to understand life course challenges experienced by transgender people since childhood.

This study aims to examine the independent and cumulative effects of unhealthy screen exposure on suicidal ideation (SI) in Chinese adolescents with depressive symptoms.

Sickle cell disease (SCD) is a lifelong disease requiring expensive treatment for management and limited curative options until the last few years. Gene therapy has emerged as a curative option for SCD, with two approved therapies available to SCD patients aged ≥ 12 years. Consideration must be considered regarding the ethics, efficacy, management requirements, education, and counseling needs of patients and their parents. Current and future practices will need to advocate for improved access and affordability of this specialized care and address the unknown and less defined areas of gene therapy pertaining to SCD through research.